Resource Centers
- Surgery for Obesity Reduces Cardiovascular Events?
- Growth Hormone Therapy May Decrease Diabetes Risk in Girls With Turner Syndrome
- Vancomycin Underdosing Very Common in the Obese
- Gestational Impaired Glucose Tolerance Linked to Postpartum Metabolic Dysfunction Outcomes
- High Fiber in Pregnancy Cuts Risk of Preeclampsia
Diabetes & Endocrinology Journals
- Plutzky on Cardiology: ACCORD and ADVANCE -- Live from the ADA Conference in San Francisco
-
Grave's Ophthalmopathy After Radiation Treatment of Thyroid Cancer
- Targeting the Interplay of Obesity, Insulin Resistance and Mixed Dyslipidemia: An Integrative Approach to Reducing Cardiometabolic Risk
- Blood Pressure, Diabetes, Gender, and Race -- What, When, How It Is, or Is Not, Treated
Medscape Community Resources
- Physicians for Sale: How Medical Professional Organizations Exploit Their Members
- Building Physician Connectivity for e-Prescribing
- Blood Pressure, Diabetes, Gender, and Race -- What, When, How It Is, or Is Not, Treated
- Diabetes Prevention and Ralph DeFronzo
- Insulin Therapy in Type 2 Diabetes: Primary Care Challenges and Solutions
POLL
PhRMA recently announced that its code of conduct now bans gifts such as pens and meals to prescribing clinicians from drug company sales reps. PhRMA says the updated code will reduce the perception of influence, but critics say the new code doesn't go far enough. What effect do you think this code will have on prescribers?
Expert Video Blogs
Diabetes & Endocrinology CME
- Barrett Esophagus: Prevalence of Central Adiposity, Metabolic Syndrome, and a Proinflammatory State
- Targeting the Interplay of Obesity, Insulin Resistance and Mixed Dyslipidemia: An Integrative Approach to Reducing Cardiometabolic Risk
- New Approaches to Managing Dyslipidemia: Risk Reduction Beyond LDL-C
- The Pathogenesis of Diabetic Nephropathy
- Dietary Fructose Consumption Among US Children and Adults: The Third National Health and Nutrition Examination Survey
Advisory Board
Editorial Director
